227 related articles for article (PubMed ID: 27017931)
1. Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.
Peek GW; Tollefsbol TO
Exp Cell Res; 2016 May; 344(1):95-102. PubMed ID: 27017931
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial PX-866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF-7 Breast Cancer Cells.
Peek GW; Tollefsbol TO
J Cell Biochem; 2016 Jul; 117(7):1688-96. PubMed ID: 26660119
[TBL] [Abstract][Full Text] [Related]
3. Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells.
Doshida M; Ohmichi M; Tsutsumi S; Kawagoe J; Takahashi T; Du B; Mori-Abe A; Ohta T; Saitoh-Sekiguchi M; Takahashi K; Kurachi H
J Biol Chem; 2006 Aug; 281(34):24270-8. PubMed ID: 16798746
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line.
Kawagoe J; Ohmichi M; Takahashi T; Ohshima C; Mabuchi S; Takahashi K; Igarashi H; Mori-Abe A; Saitoh M; Du B; Ohta T; Kimura A; Kyo S; Inoue M; Kurachi H
J Biol Chem; 2003 Oct; 278(44):43363-72. PubMed ID: 12917431
[TBL] [Abstract][Full Text] [Related]
5. Cordyceptin induces apoptosis through repressing hTERT expression and inducing extranuclear export of hTERT.
Jang KJ; Kwon GS; Jeong JW; Kim CH; Yoon HM; Kim GY; Shim JH; Moon SK; Kim WJ; Choi YH
J Biosci Bioeng; 2015 Mar; 119(3):351-7. PubMed ID: 25282637
[TBL] [Abstract][Full Text] [Related]
6. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
7. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin activates telomerase through transcriptional and posttranscriptional regulation in human erythroleukemic JAS-REN-A cells.
Akiyama M; Kawano T; Mikami-Terao Y; Agawa-Ohta M; Yamada O; Ida H; Yamada H
Leuk Res; 2011 Mar; 35(3):416-8. PubMed ID: 21163530
[TBL] [Abstract][Full Text] [Related]
10. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
11. Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.
Gaben AM; Sabbah M; Redeuilh G; Bedin M; Mester J
BMC Cancer; 2012 Jul; 12():291. PubMed ID: 22799881
[TBL] [Abstract][Full Text] [Related]
12. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
13. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
Zhang X; Min KW; Wimalasena J; Baek SJ
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2051-60. PubMed ID: 22814742
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism.
Yang YL; Huang PH; Chiu HC; Kulp SK; Chen CS; Kuo CJ; Chen HD; Chen CS
Biochem Biophys Res Commun; 2013 May; 435(1):107-12. PubMed ID: 23624506
[TBL] [Abstract][Full Text] [Related]
16. Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16.
Bai T; Liu F; Zou F; Zhao G; Jiang Y; Liu L; Shi J; Hao D; Zhang Q; Zheng T; Zhang Y; Liu M; Li S; Qi L; Liu JY
Stem Cells Dev; 2017 Jan; 26(2):113-122. PubMed ID: 27702388
[TBL] [Abstract][Full Text] [Related]
17. Expression of PRIP, a phosphatidylinositol 4,5-bisphosphate binding protein, attenuates PI3K/AKT signaling and suppresses tumor growth in a xenograft mouse model.
Maetani Y; Asano S; Mizokami A; Yamawaki Y; Sano T; Hirata M; Irifune M; Kanematsu T
Biochem Biophys Res Commun; 2021 May; 552():106-113. PubMed ID: 33743346
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
19. Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells.
Mazars P; Barboule N; Baldin V; Vidal S; Ducommun B; Valette A
FEBS Lett; 1995 Apr; 362(3):295-300. PubMed ID: 7729516
[TBL] [Abstract][Full Text] [Related]
20. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines.
Kimura A; Ohmichi M; Kawagoe J; Kyo S; Mabuchi S; Takahashi T; Ohshima C; Arimoto-Ishida E; Nishio Y; Inoue M; Kurachi H; Tasaka K; Murata Y
Oncogene; 2004 Jun; 23(26):4505-15. PubMed ID: 15048073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
